Navigation Links
Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Date:4/24/2012

aboration with the UW Carbone Cancer Center," said Harry Palmin, President and CEO of Novelos. "We believe these data begin to establish proof-of-concept for LIGHT as a PET imaging agent for NSCLC, could advance our partnering discussions and could be used to calculate effective doses for Phase 2 clinical trials of I-131-CLR1404 (HOT). HOT is our chemically identical small-molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic that delivers cytotoxic radiation directly and selectively to cancer cells and cancer stem cells."

About LIGHT
LIGHT is a small molecule imaging agent that we believe has first-in-class potential for selective detection of tumors and metastases in a broad range of cancers. LIGHT is comprised of a small, non-pharmacological quantity of CLR1404 (COLD, acting as a cancer-targeted delivery and retention vehicle) labeled with the short-lived radioisotope, iodine-124, a new PET imaging isotope. PET imaging used in conjunction with CT scanning has now become the imaging method of choice in oncology. In studies to date, LIGHT selectively illuminated malignant tumors in 52 of 54 animal models of cancer, demonstrating broad-spectrum, cancer-selective uptake and retention.  Investigator-sponsored Phase 1-2 trials of LIGHT as a PET imaging agent are ongoing. The trials include lung cancer, brain cancer and, starting in the second quarter of 2012, other solid tumors. These human trials, if successful, will serve three important purposes. First, they would provide proof-of-concept for LIGHT itself as a PET imaging agent with the potential to supplant the current "gold standard" agent, 18-fluoro-deoxyglucose (FDG), due to what we believe to be LIGHT's superior cancer-specificity and more favorable logistics of clinical use. Second, favorable results would advance partnering discussions for LIGHT. Third, tumor uptake data will accelerate clinical development of HOT by predic
'/>"/>

SOURCE Novelos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
2. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
3. Novelos Therapeutics Announces Dismissal of Putative Federal Securities Class Action Lawsuit
4. Novelos Therapeutics Prices $5.9 Million Public Offering
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... TUCSON, Ariz. , July 22, 2014 /PRNewswire/ ... recipient of a SynCardia temporary Total ... of Rochester,s Strong Memorial Hospital with the Freedom® ... heart. Fontana, a 64-year-old retiree from ... disease—cardiomyopathy—for decades. He managed the condition with medications, ...
(Date:7/22/2014)... 22, 2014 The Intellectual ... , the world,s leading provider of intelligent ... Cortellis Clinical Trials Intelligence , its ... milestone with the documentation of more than ... with greater and quicker access to critical ...
(Date:7/22/2014)... SHANGHAI , July 22, 2014 WuXi PharmaTech ... biotechnology and medical device R&D outsourcing company with operations in ... States , today announced that it will release financial ... York Stock Exchange closes on Wednesday, August 13, 2014 (which ... earnings release will be available on the investor relations section ...
Breaking Medicine Technology:'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
(Date:7/22/2014)... Men and women who are fighting ... of their disposable income each year on different retail ... best anti aging products guide to help introduce natural ... is now released and accessible from any tablet, PC ... were selected and inserted into the guide to help ...
(Date:7/22/2014)... July 22, 2014 Print Audit® ... Audit Facilities Manager web portal. Facilities Manager 3.1.0R ... of the software as well as numerous new ... Print Audit Facilities Manager is a powerful, easy ... remotely collect meter reads, automate supplies fulfillment and ...
(Date:7/22/2014)... Ticket Down is a reliable source for ... at Sporting Park in Kansas City, MO. This friendly ... Tickets can be conveniently printed out for this exciting match ... reached toll free at 1-877-870-3653. All tickets for Sporting ... Ticket Down's customer satisfaction guarantee. , About TicketDown.com: , ...
(Date:7/22/2014)... July 22, 2014 Vitamin C is one ... creams mostly marketed to women in the United States. The ... for wrinkles list online for women to review at ... and oils is one way that beauty product manufacturers are ... approach, many companies are using mixtures of Vitamins C, E ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses and special ... white party dresses to its product category. Additionally, ... available on its website. As a special offer, all customers ... get a discounted rate, up to 54% off. , A ... so its marketing specialist believes the new white party dresses ...
Breaking Medicine News(10 mins):Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Best Vitamin C Serum for Wrinkles List Complied for Women at Consumer News Portal Online 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... , March 10 Smart Balance, Inc. (Nasdaq: SMBL ) announced today that Stephen Hughes , Chairman and Chief Executive Officer of Smart Balance, ... Tuesday, March 16, 2010 . , ... , , ... ...
... technological revolution, the "light fantastic" continues to impact people,s ... and performing intricate surgery. As the golden anniversary of ... 7th, Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ... exciting future of this amazing invention. C&EN ...
... may someday extend men,s lives, , WEDNESDAY, March 10 ... in treating late-stage prostate cancer, it often results in ... to such therapy. , Now, however, researchers working with ... the secondary tumors gain their resistance -- a finding ...
... ... investment banking and business development to LeveragePoint,s Board of Directors. , ... Cambridge, MA (PRWEB) March 10, ... Value Management software for marketing and sales, today announced that entrepreneurial advisor and seasoned ...
... ... ... , , , , ... ...
... , ... ... , , , ... ...
Cached Medicine News:Health News:Smart Balance to Present at Roth Growth Stock Conference 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:Peyton Marshall Joins LeveragePoint Innovations Board 2Health News:Peyton Marshall Joins LeveragePoint Innovations Board 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 2Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 4Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 5Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 6Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 2Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 3Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 4Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 5
... is designed for the treatment of diaphyseal ... preformed design provides post operative support following ... or external fixation. The brace allows for ... fracture site, increasing vascularity and encouraging bone ...
The UltraLite Post Op Brace provides a fixed or range of motion control. The UltraLite Post Op Brace indications include: , Post knee trauma , Peri-operative use , Conservative management of isolated...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: